Cargando…
Serum neopterin levels in relation to mild and severe COVID-19
BACKGROUND: The COVID-19 pandemic, caused by the coronavirus SARS-CoV-2, is rapidly spreading worldwide. There is limited information about prognostic markers that could help clinicians to identify COVID-19 patients with a poor prognosis. Serum levels of the immune activation marker neopterin has sh...
Autores principales: | Robertson, Josefina, Gostner, Johanna M., Nilsson, Staffan, Andersson, Lars-Magnus, Fuchs, Dietmar, Gisslen, Magnus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726600/ https://www.ncbi.nlm.nih.gov/pubmed/33302893 http://dx.doi.org/10.1186/s12879-020-05671-7 |
Ejemplares similares
-
Residual Central Nervous System Immune Activation Is Not Prevented by Antiretroviral Therapy Initiated During Early Chronic HIV Infection
por: Edén, Arvid, et al.
Publicado: (2023) -
Association between Plasma Homocysteine Levels and Neuronal Injury in HIV Infection
por: Ahlgren, Erika, et al.
Publicado: (2016) -
Cerebrospinal fluid neopterin decay characteristics after initiation of antiretroviral therapy
por: Yilmaz, Aylin, et al.
Publicado: (2013) -
Comparable endemic coronavirus nucleoprotein‐specific antibodies in mild and severe Covid‐19 patients
por: Leach, Susannah, et al.
Publicado: (2021) -
Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection
por: Hagberg, Lars, et al.
Publicado: (2010)